Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Ochoa-Repáraz

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
FEBS Letters|October 7, 2014
Gut microbiome and the risk factors in central nervous system autoimmunityJavier Ochoa-Repáraz, Lloyd H Kasper
Translational Research : the Journal of Laboratory and Clinical Medicine|August 14, 2016
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating diseaseJavier Ochoa-Repáraz, Lloyd H Kasper
Current Obesity Reports|February 12, 2016
The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?Javier Ochoa-Repáraz, Lloyd H Kasper
Frontiers in Immunology|October 12, 2020
Editorial: The Role of the Gut Microbiota in Health and Inflammatory DiseasesAshutosh K Mangalam, Javier Ochoa-Repáraz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 18, 2018
The Microbiome and Neurologic Disease: Past and Future of a 2-Way InteractionJavier Ochoa-Repáraz, Lloyd H Kasper
Medical Sciences (Basel, Switzerland)|August 29, 2018
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic AvenueTrevor O Kirby, Javier Ochoa-Repáraz
Annals of Translational Medicine|May 3, 2017
The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosisJavier Ochoa-Repáraz, Krisztian Magori, Lloyd H Kasper
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Gut commensalism, cytokines, and central nervous system demyelinationKiel Telesford, Javier Ochoa-Repáraz, Lloyd H Kasper
Diseases (Basel, Switzerland)|September 3, 2020
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?Hannah M Kohl, Andrea R Castillo, Javier Ochoa-Repáraz
Frontiers in Immunology|November 16, 2020
A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric DisordersJavier Ochoa-Repáraz, Christina C Ramelow, Lloyd H Kasper
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
FEBS Letters|October 7, 2014
Gut microbiome and the risk factors in central nervous system autoimmunityJavier Ochoa-Repáraz, Lloyd H Kasper
Translational Research : the Journal of Laboratory and Clinical Medicine|August 14, 2016
The influence of gut-derived CD39 regulatory T cells in CNS demyelinating diseaseJavier Ochoa-Repáraz, Lloyd H Kasper
Current Obesity Reports|February 12, 2016
The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?Javier Ochoa-Repáraz, Lloyd H Kasper
Frontiers in Immunology|October 12, 2020
Editorial: The Role of the Gut Microbiota in Health and Inflammatory DiseasesAshutosh K Mangalam, Javier Ochoa-Repáraz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 18, 2018
The Microbiome and Neurologic Disease: Past and Future of a 2-Way InteractionJavier Ochoa-Repáraz, Lloyd H Kasper
Medical Sciences (Basel, Switzerland)|August 29, 2018
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic AvenueTrevor O Kirby, Javier Ochoa-Repáraz
Annals of Translational Medicine|May 3, 2017
The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosisJavier Ochoa-Repáraz, Krisztian Magori, Lloyd H Kasper
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 2, 2014
Gut commensalism, cytokines, and central nervous system demyelinationKiel Telesford, Javier Ochoa-Repáraz, Lloyd H Kasper
Diseases (Basel, Switzerland)|September 3, 2020
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?Hannah M Kohl, Andrea R Castillo, Javier Ochoa-Repáraz
Frontiers in Immunology|November 16, 2020
A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric DisordersJavier Ochoa-Repáraz, Christina C Ramelow, Lloyd H Kasper
Pageof 5